Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Chinese (SSE) Healthcare Sector Analysis

UpdatedMar 01, 2026
DataAggregated Company Financials
Companies472
  • 7D0.4%
  • 3M-2.1%
  • 1Y11.3%
  • YTD-1.6%

The Healthcare is pretty flat in the last 7 days, but Wedge IndustrialLtd has stood out, gaining 27%. As for the the longer term, the industry is up 11% over the past 12 months. As for the next few years, earnings are expected to grow by 24% per annum.

Sector Valuation and Performance

Has the Chinese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 01 Mar 2026CN¥6.4tCN¥2.3tCN¥146.6b41.3x43.9x2.8x
Tue, 27 Jan 2026CN¥6.7tCN¥2.3tCN¥145.1b43.1x46x2.9x
Thu, 25 Dec 2025CN¥6.4tCN¥2.3tCN¥145.1b39.2x44.1x2.8x
Sat, 22 Nov 2025CN¥6.4tCN¥2.3tCN¥145.1b38.5x44.1x2.8x
Mon, 20 Oct 2025CN¥6.6tCN¥2.3tCN¥146.7b39.5x45.2x2.9x
Wed, 17 Sep 2025CN¥7.0tCN¥2.2tCN¥142.2b41.2x49.2x3.2x
Fri, 15 Aug 2025CN¥6.8tCN¥2.2tCN¥152.8b40.4x44.5x3.1x
Sun, 13 Jul 2025CN¥6.2tCN¥2.2tCN¥150.0b36.9x41.2x2.8x
Tue, 10 Jun 2025CN¥6.2tCN¥2.2tCN¥150.1b36.4x41x2.8x
Thu, 08 May 2025CN¥5.6tCN¥2.2tCN¥149.7b33.2x37.6x2.6x
Sat, 05 Apr 2025CN¥5.8tCN¥2.2tCN¥158.8b33.2x36.7x2.6x
Mon, 03 Mar 2025CN¥5.6tCN¥2.2tCN¥153.8b31.8x36.6x2.5x
Wed, 29 Jan 2025CN¥5.4tCN¥2.2tCN¥153.8b30.9x34.9x2.4x
Fri, 27 Dec 2024CN¥5.7tCN¥2.2tCN¥153.7b32.1x36.9x2.5x
Sun, 24 Nov 2024CN¥5.7tCN¥2.2tCN¥154.1b33x37.3x2.6x
Tue, 22 Oct 2024CN¥5.8tCN¥2.2tCN¥162.0b32.4x35.8x2.6x
Thu, 19 Sep 2024CN¥4.7tCN¥2.2tCN¥161.5b26.5x29.2x2.1x
Sat, 17 Aug 2024CN¥5.1tCN¥2.3tCN¥166.7b28.5x30.9x2.3x
Mon, 15 Jul 2024CN¥5.1tCN¥2.3tCN¥167.0b28.1x30.8x2.3x
Wed, 12 Jun 2024CN¥5.5tCN¥2.3tCN¥164.9b29.8x33.5x2.4x
Fri, 10 May 2024CN¥6.1tCN¥2.3tCN¥167.5b33.8x36.7x2.7x
Sun, 07 Apr 2024CN¥5.8tCN¥2.3tCN¥172.9b30.7x33.5x2.5x
Tue, 05 Mar 2024CN¥6.0tCN¥2.3tCN¥179.0b30.6x33.5x2.6x
Thu, 01 Feb 2024CN¥5.3tCN¥2.3tCN¥177.1b27.2x30.1x2.3x
Sat, 30 Dec 2023CN¥6.5tCN¥2.3tCN¥177.1b34.8x36.8x2.8x
Mon, 27 Nov 2023CN¥6.7tCN¥2.3tCN¥177.2b37x38x2.9x
Wed, 25 Oct 2023CN¥6.1tCN¥2.3tCN¥186.5b31.4x32.9x2.7x
Fri, 22 Sep 2023CN¥6.2tCN¥2.3tCN¥185.1b31.4x33.7x2.7x
Sun, 20 Aug 2023CN¥6.2tCN¥2.3tCN¥192.2b31.5x32.3x2.7x
Tue, 18 Jul 2023CN¥6.5tCN¥2.3tCN¥192.9b33.4x33.7x2.9x
Thu, 15 Jun 2023CN¥6.7tCN¥2.3tCN¥191.7b34.6x34.7x2.9x
Sat, 13 May 2023CN¥6.9tCN¥2.3tCN¥205.8b35.4x33.3x3x
Mon, 10 Apr 2023CN¥7.3tCN¥2.2tCN¥235.9b37.3x30.8x3.2x
Wed, 08 Mar 2023CN¥7.3tCN¥2.2tCN¥229.6b38.1x31.6x3.3x
Price to Earnings Ratio

31.6x


Total Market Cap: CN¥7.3tTotal Earnings: CN¥229.6bTotal Revenue: CN¥2.2tTotal Market Cap vs Earnings and Revenue0%0%0%
Chinese Healthcare Sector Price to Earnings3Y Average 36.9x202420252026
Current Industry PE
  • Investors are optimistic on the Chinese Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 43.9x which is higher than its 3-year average PE of 36.9x.
  • The industry is trading close to its 3-year average PS ratio of 2.7x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 14% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Chinese Healthcare sector?

CN Market2.79%
Healthcare0.35%
Medical Equipment2.10%
Healthcare Services1.46%
Biotech0.59%
Pharma-0.13%
Healthtech-1.66%
Life Sciences-2.24%
Industry PE
  • Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 89.4x.
    • Analysts are expecting annual earnings growth of 36.8%, which is higher than its past year's earnings decline of 8.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 93% over the next 5 years.
  • This is roughly in line with its past earnings growth rate.
  • In contrast, the Life Sciences industry is expected to see its earnings grow by 20% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
000534 Wedge IndustrialLtdCN¥41.8527.0%
+CN¥4.3b		178.4%PE90.2x
688271 Shanghai United Imaging HealthcareCN¥130.703.7%
+CN¥3.9b		-3.1%PE56.8x
000661 Changchun High-Tech Industry (Group)CN¥95.779.6%
+CN¥3.4b		0.8%PE40.2x
300255 Hebei Changshan Biochemical PharmaceuticalCN¥46.658.1%
+CN¥3.2b		133.1%PS46.2x
300677 Intco Medical TechnologyCN¥43.8611.5%
+CN¥2.9b		77.2%PE16.7x

Latest News

301580
CN¥87.00
Aidite (Qinhuangdao) Technology
7D
36.9%
1Y
124.9%
688617
CN¥246.24
APT Medical
7D
5.9%
1Y
0.3%
301363
CN¥31.27
MeHow Innovative
7D
-10.3%
1Y
51.8%
688271
CN¥130.70
Shanghai United Imaging Healthcare
7D
3.7%
1Y
-3.1%
002422
CN¥30.54
Sichuan Kelun Pharmaceutical
7D
-3.2%
1Y
3.5%

002422: Share Repurchase And New Agreements Will Support Balanced Medium Term Outlook

Analysts have revised their price target for Sichuan Kelun Pharmaceutical from CN¥30 to CN¥29, reflecting updated views that incorporate more moderate revenue growth assumptions, slightly higher profit margins, and a small adjustment to the forward P/E and discount rate inputs. What's in the News Sichuan Kelun Pharmaceutical Co., Ltd.
603259
CN¥98.01
WuXi AppTec
7D
-3.8%
1Y
60.3%

603259: Upgraded Outlook Will Rely On Execution To Unlock Upside

Analysts have lifted their price target on WuXi AppTec from CN¥89.70 to CN¥123.00, citing updated assumptions for fair value, discount rate, revenue growth, profit margins and future P/E following recent Street research. Analyst Commentary While some research, including a recent upgrade from Goldman Sachs, points to upside based on revised assumptions, there is still a group of bearish analysts highlighting risks that could limit how much of that upside is realized.
000534
CN¥41.85
Wedge IndustrialLtd
7D
27.0%
1Y
178.4%
600276
CN¥56.56
Jiangsu Hengrui PharmaceuticalsLtd
7D
-2.9%
1Y
23.1%
300255
CN¥46.65
Hebei Changshan Biochemical Pharmaceutical
7D
8.1%
1Y
133.1%
300677
CN¥43.86
Intco Medical Technology
7D
11.5%
1Y
77.2%
002294
CN¥49.11
Shenzhen Salubris Pharmaceuticals
7D
-3.3%
1Y
65.2%
300015
CN¥10.60
Aier Eye Hospital Group
7D
2.6%
1Y
-23.7%
000661
CN¥95.77
Changchun High-Tech Industry (Group)
7D
9.6%
1Y
0.8%
688266
CN¥82.12
Suzhou Zelgen Biopharmaceuticals
7D
-13.0%
1Y
0.06%
688506
CN¥264.60
Sichuan Biokin PharmaceuticalLtd
7D
-7.8%
1Y
13.6%
600436
CN¥163.24
Zhangzhou Pientzehuang Pharmaceutical
7D
-2.6%
1Y
-20.2%